Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27780192 | 0.77 | MAPK1 (0.38) | MAPK1 | |
| SCHEMBL11026448 | 0.73 | — | — | |
| SCHEMBL875827 | 0.73 | MEN1 (0.30) | — | |
| SCHEMBL27991660 | 0.72 | TSHR (0.33) | — | |
| SCHEMBL15268533 | 0.71 | — | — | |
| SCHEMBL7729854 | 0.67 | — | — | |
| SCHEMBL875141 | 0.63 | — | — | |
| SCHEMBL10676865 | 0.62 | — | — | |
| SCHEMBL17629692 | 0.62 | ROCK2 (0.44) | — | |
| SCHEMBL9162185 | 0.60 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 433 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11717532-B2 | Methods and compositions for treating wounds utilizing chitosan compounds | SYNEDGEN, INC. (US) | 2023-08-08 | — | — | US | claimed |
| US-11071795-B2 | Indicating devices based on etching of metals | JP LABORATORIES INC. (US) | 2021-07-27 | — | — | US | claimed |
| US-20180024011-A1 | Indicating Devices Based on Etching of Metals | JP LABORATORIES INC. | 2018-01-25 | — | — | US | claimed |
| US-8557730-B2 | Composition and process for making the composition | MOLYCORP MINERALS, LLC (US) | 2013-10-15 | — | — | US | claimed |
| US-8343437-B2 | Monitoring system based on etching of metals | JP LABORATORIES, INC. (US) | 2013-01-01 | — | — | US | claimed |
| US-8252087-B2 | Process and apparatus for treating a gas containing a contaminant | MOLYCORP MINERALS, LLC (US) | 2012-08-28 | — | — | US | claimed |
| JP-2011530085-A | — | — | 2011-12-15 | — | — | JP | claimed |
| EP-2288879-A1 | A MONITORING SYSTEM BASED ON ETCHING OF METALS | Patel, G (US) | 2011-03-02 | — | — | EP | claimed |
| US-20100168498-A1 | APPARATUS AND PROCESS FOR TREATING AN AQUEOUS SOLUTION CONTAINING CHEMICAL CONTAMINANTS | MOLYCORP MINERALS, LLC (US) | 2010-07-01 | — | — | US | claimed |
| US-20090301382-A1 | Monitoring System Based on Etching of Metals | JP LABORATORIES, INC | 2009-12-10 | — | — | US | claimed |
| EP-1926682-A2 | SIGNAL ACTIVATED DECONTAMINATING COATING | Crosslink Polymer Research (US) | 2008-06-04 | — | — | EP | claimed |
| WO-2008018856-A2 | SIGNAL ACTIVATED DECONTAMINATING COATING | CROSSLINK POLYMER RESEARCH (US) | 2008-02-14 | — | — | WO | claimed |
| US-20070114121-A1 | Signal activated decontaminating coating | CROSSLINK POLYMER RESEARCH (US) | 2007-05-24 | — | — | US | claimed |
| CN-1370170-A | DNA methyltransferase inhibitors | PENN STATE RES FOUND (US) | 2002-09-18 | — | — | CN | claimed |
| WO-2002002192-A1 | FORMULATIONS FOR NEUTRALIZATION OF CHEMICAL AND BIOLOGICAL TOXANTS | SANDIA CORPORATION (US) | 2002-01-10 | — | — | WO | claimed |
| EP-1166825-A1 | Formulations for neutralization of chemical and biological toxants | Sandia Corporation (US) | 2002-01-02 | — | — | EP | claimed |
| EP-0783682-B1 | DETECTION OF SULPHUR CONTAINING COMPOUNDS | SECR DEFENCE (GB) | 1999-07-21 | — | — | EP | claimed |
| US-5759861-A | OXIDIZING SAMPLE, MEASURING CHEMILUMINESCENCE | SECRETARY OF STATE FOR DEFENCE IN HER BRITANNIC MAJESTY'S GOVERNMENT OF THE U.K. OF GT. BRITAIN & NORTHERN IRELAND OF DEFENCE EVALUATION & RESEARCH AGENCY (GB) | 1998-06-02 | — | — | US | claimed |
| EP-0783682-A1 | DETECTION OF SULPHUR CONTAINING COMPOUNDS | THE SECRETARY OF STATE FOR DEFENCE (GB) | 1997-07-16 | — | — | EP | claimed |
| WO-1996010169-A1 | DETECTION OF SULPHUR CONTAINING COMPOUNDS | THE SECRETARY OF STATE FOR DEFENCE (GB) | 1996-04-04 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11717532-B2 | Methods and compositions for treating wounds utilizing chitosan compounds | CHIA, MMP8, CHIT1 | MAPK1 3263/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.